Sprouts (SFM) insider files Form 144 for 8,090 shares sale

Rhea-AI Filing Summary

Notice of proposed sale under Rule 144 by an insider of Sprouts Farmers Market, Inc. (SFM). The filer intends to sell 8,090 shares of common stock through Goldman Sachs & Co. LLC on or about 10/06/2025, with an aggregate market value of 823,238.4 and 97,726,169 shares outstanding noted. The securities were originally acquired on 03/09/2020 as compensation via stock options and exercised with a same-day cashless exercise.

The filing also discloses six prior small open-market sales by the named seller totaling 24,270 shares between 07/07/2025 and 09/03/2025, with reported gross proceeds for each trade shown. The signer represents no undisclosed material adverse information and references Rule 10b5-1 trading plan language if applicable.

Positive

• Sale size is small relative to shares outstanding (8,090 vs 97,726,169), suggesting limited market impact
• Securities were acquired as compensation and exercised via cashless exercise, indicating an expected source of shares rather than an external financing need

Negative

• Insider has executed multiple recent sales (six trades totaling 24,270 shares between 07/07/2025 and 09/03/2025), which could indicate ongoing disposition
• Filing lacks explicit mention of a dated Rule 10b5-1 plan, so timing may be interpreted by some market participants as discretionary selling

Insights

Corporate Insider Transactions Analyst

Insider is selling a modest stake from compensation-held shares; recent prior sales suggest ongoing disposition.

The filing shows an intended sale of 8,090 shares acquired as compensation on 03/09/2020, executed via a cashless exercise and routed through Goldman Sachs & Co. LLC. The insider previously sold 4045 shares on six occasions totaling 24,270 shares this summer and early fall, with individual gross proceeds reported for each trade.

Primary dependencies include whether these sales are part of a structured trading plan under Rule 10b5-1 and the pace of future dispositions; monitor for additional Form 144s or Form 4s in the coming weeks for confirmation.

Equity Liquidity Specialist

Transaction size is small relative to total shares outstanding, so market impact is likely limited.

The aggregate sale of 8,090 shares against 97,726,169 shares outstanding represents a very small fraction of the float, and the reported aggregate market value is 823,238.4. Trades routed through a major broker suggest routine execution rather than a financing event.

Watch for any clustering of further insider sales within 30 days, which could increase temporary liquidity pressure; absent additional disclosures, this filing appears routine.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	8090	823238.4	97726169	10/06/2025	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/09/2020	Acquired as compensation -- Stock Options	Issuer			8090	03/09/2020	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jack Sinclair 5455 East High Street Suite 111 Phoenix AZ 85054	Common	09/03/2025	4045	555208.61
Jack Sinclair 5455 East High Street Suite 111 Phoenix AZ 85054	Common	09/02/2025	4045	560619.2
Jack Sinclair 5455 East High Street Suite 111 Phoenix AZ 85054	Common	07/07/2025	4045	659073.69
Jack Sinclair 5455 East High Street Suite 111 Phoenix AZ 85054	Common	07/08/2025	4045	649763.72
Jack Sinclair 5455 East High Street Suite 111 Phoenix AZ 85054	Common	08/04/2025	4045	634088.94
Jack Sinclair 5455 East High Street Suite 111 Phoenix AZ 85054	Common	08/05/2025	4045	612228.95

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Sprouts Farmers Market (SFM) disclose?

It discloses an intended sale of 8,090 common shares through Goldman Sachs & Co. LLC on or about 10/06/2025 with an aggregate market value of 823,238.4.

Who acquired the shares being sold and when?

The shares were acquired on 03/09/2020 as compensation via stock options and were exercised using a same-day cashless exercise.

Has the insider sold shares recently?

Yes. The filing lists six prior sales by the named seller totaling 24,270 shares between 07/07/2025 and 09/03/2025, with individual gross proceeds reported.

How large is the sale relative to the company's outstanding shares?

The proposed sale of 8,090 shares is small compared with the reported 97,726,169 shares outstanding.

Does the Form 144 state whether a Rule 10b5-1 plan is being used?

The form includes language about Rule 10b5-1 plans but does not explicitly state a plan adoption date in the provided fields.